Xenetic Biosciences, Inc.
XBIO
$4.11
-$0.17-3.97%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.26M | 3.19M | 2.98M | 2.86M | 2.45M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.26M | 3.19M | 2.98M | 2.86M | 2.45M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 3.26M | 3.19M | 2.98M | 2.86M | 2.45M |
| SG&A Expenses | 3.16M | 2.74M | 2.75M | 2.84M | 2.77M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.90M | 5.58M | 5.81M | 6.17M | 5.71M |
| Operating Income | -2.64M | -2.39M | -2.83M | -3.31M | -3.27M |
| Income Before Tax | -2.48M | -2.23M | -2.68M | -3.16M | -3.08M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.48 | -2.23 | -2.68 | -3.16 | -3.08 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.48M | -2.23M | -2.68M | -3.16M | -3.08M |
| EBIT | -2.64M | -2.39M | -2.83M | -3.31M | -3.27M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -1.20 | -1.24 | -1.63 | -2.05 | -2.00 |
| Normalized Basic EPS | -0.75 | -0.78 | -1.02 | -1.28 | -1.25 |
| EPS Diluted | -1.20 | -1.24 | -1.63 | -2.05 | -2.00 |
| Normalized Diluted EPS | -0.75 | -0.78 | -1.02 | -1.28 | -1.25 |
| Average Basic Shares Outstanding | 8.31M | 7.56M | 6.81M | 6.17M | 6.17M |
| Average Diluted Shares Outstanding | 8.31M | 7.56M | 6.81M | 6.17M | 6.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |